Fate Therapeutics Inc. sell Bank of America Co.
Start price
28.03.24
/
50%
€6.80
Target price
28.03.25
€5.56
Performance (%)
-55.28%
Price
01.10.24
€3.04
Summary
This prediction is currently active. The SELL prediction by Bank_of_America_Co_ for Fate Therapeutics Inc. is performing very well with a performance of -55.28%. This prediction currently runs until 28.03.25. The prediction end date can be changed by Bank_of_America_Co_ at any time. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Fate Therapeutics Inc. | -1.935% | -1.935% |
iShares Core DAX® | 1.164% | 1.549% |
iShares Nasdaq 100 | 0.118% | 0.969% |
iShares Nikkei 225® | 1.124% | -1.120% |
iShares S&P 500 | 0.479% | 1.068% |
Comments by Bank_of_America_Co_ for this prediction
In the thread Fate Therapeutics Inc. diskutieren
Fate Therapeutics, Inc. (NASDAQ: FATE) had its price target raised by analysts at Bank of America Co. from $2.00 to $6.00. They now have an "underperform" rating on the stock.
Ratings data for FATE provided by MarketBeat